Precipio Pre-Tax Income 2010-2025 | PRPO
Precipio pre-tax income from 2010 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
| Precipio Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $-4 |
| 2023 | $-6 |
| 2022 | $-12 |
| 2021 | $-9 |
| 2020 | $-11 |
| 2019 | $-13 |
| 2018 | $-16 |
| 2017 | $-21 |
| 2016 | $-2 |
| 2015 | $-10 |
| 2014 | $-11 |
| 2013 | $-16 |
| 2012 | $-8 |
| 2011 | $-10 |
| 2010 | $-3 |
| 2009 | $-2 |
| Precipio Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-1 |
| 2024-12-31 | $0 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-1 |
| 2024-03-31 | $-2 |
| 2023-12-31 | $1 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-5 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-4 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-7 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-10 |
| 2017-09-30 | $-6 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $1 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-2 |
| 2014-12-31 | $1 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-4 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-3 |
| 2010-12-31 | $-1 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.016B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||